The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
ASPP Proteins Specifically Stimulate the Apoptotic Function of p53
Open accessAbstract
We identified a family of proteins termed ASPP. ASPP1 is a protein homologous to 53BP2, the C-terminal half of ASPP2. ASPP proteins interact with p53 and specifically enhance p53-induced apoptosis but not cell cycle arrest. Inhibition of endogenous ASPP function suppresses the apoptotic function of endogenous p53 in response to apoptotic stimuli. ASPP enhance the DNA binding and transactivation function of p53 on the promoters of proapoptotic genes in vivo. Two tumor-derived p53 mutants with reduced apoptotic function were defective in cooperating with ASPP in apoptosis induction. The expression of ASPP is frequently downregulated in human breast carcinomas expressing wild-type p53 but not mutant p53. Therefore, ASPP regulate the tumor suppression function of p53 in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The miR-21 targets we identified included p53 homologue, p63, p53 activators JMY, TOPORS, TP53BP2, DAXX, and HNRPK, which can stabilize p53 protein levels by interfering with MDM2 and/or act as p53 transcriptional cofactors, assisting p53 in transactivating genes that can induce apoptosis and growth arrest (21)(22)(23)(24)(25)(26).”
From MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells (2008) · cites this paper as [23]
Citations
Cites
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,318
p53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346
Structure of the p53 Tumor Suppressor Bound to the Ankyrin and SH3 Domains of 53BP2
Gorina, S. S., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.1001 · Cited by 575
Two cellular proteins that bind to wild-type but not mutant p53.
Iwabuchi, K., Bartel, P. L., Li, B., Marraccino, R. L., & Fields, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.13.6098 · Cited by 432
In vivo gene expression profile analysis of human breast cancer progression.
Sgroi, D. C., Teng, S., ROBINSON, G. C., LeVangie, R., Hudson, J. R., & Elkahloun, A. G. (1999) · PubMed · Cited by 390
Differential Activation of Target Cellular Promoters by p53 Mutants with Impaired Apoptotic Function
Ludwig, R. L., Bates, S., & Vousden, K. H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4952 · Cited by 278
Hsieh, J.-K., Fredersdorf, S., Kouzarides, T., Martin, K., & Lü, X. (1997) · Genes & Development · doi:10.1101/gad.11.14.1840 · Cited by 278
Self-citationA Mutant p53 That Discriminates between p53-Responsive Genes Cannot Induce Apoptosis
Friedlander, P. A., Haupt, Y., Prives, C. L., & Oren, M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4961 · Cited by 277
Stimulation of p53-mediated Transcriptional Activation by the p53-binding Proteins, 53BP1 and 53BP2
Iwabuchi, K., Li, B., Massa, H. F., Trask, B. J., Date, T., & Fields, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.26061 · Cited by 206
Crook, T., Brooks, L. A., Crossland, S., Osin, P., Barker, K. T., Waller, J., Philp, E., Smith, P. D., Yuluğ, I. G., Peto, J., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1202106 · Cited by 179
Self-citation
Cited by
Sorted by citations
Items 401–500 of 663
Kramer, D., Schön, M., Bayerlová, M., Bleckmann, A., Schön, M. P., Zörnig, M., & Dobbelstein, M. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.17 · Cited by 17
Insights into the structure and protein–protein interactions of the pro-apoptotic protein ASPP2
Rotem, S., Katz, C., & Friedler, A. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350966 · Cited by 17
p53 functions and cell lines: Have we learned the lessons from the past?
Millau, J., Mai, S., Bastien, N., & Drouin, R. (2010) · BioEssays · doi:10.1002/bies.200900160 · Cited by 16
Faherty, C. S., Merrell, D. S., Semino‐Mora, C., Dubois, A., Ramaswamy, A. V., & Maurelli, A. T. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-272 · Cited by 17
Binding site comparisons for target-centered drug discovery
Konc, J. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1588883 · Cited by 16
Phosphorylation of ASPP2 by RAS/MAPK Pathway Is Critical for Its Full Pro-Apoptotic Function
Godin-Heymann, N., Wang, Y., Slee, E. A., & Lü, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082022 · Cited by 16
ASPP2 Plays a Dual Role in gp120-Induced Autophagy and Apoptosis of Neuroblastoma Cells
Liu, Z., Qiao, L., Zhang, Y., Zang, Y., Shi, Y., Liu, K., Zhang, X., Lu, X., Yuan, L., Su, B., et al. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00150 · Cited by 16
Self-citationmiR-219a-5p Ameliorates Hepatic Ischemia/Reperfusion Injury via Impairing TP53BP2
Yu, X., Zhang, S., Li, Q., Liu, Z., Mai, W., Chen, W., Lei, J., & Hu, H. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05535-4 · Cited by 16
Millau, J., Bastien, N., Bouchard, É. F., & Drouin, R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2036 · Cited by 16
The role of ankyrin repeat-containing proteins in epigenetic and transcriptional regulation
Wu, M., Zhao, Y., Yang, J., Yang, F., Dai, Y., Wang, Q., Chen, C., & Chu, X. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02519-4 · Cited by 16
Cytoplasmic iASPP Expression as a Novel Prognostic Indicator in Oral Cavity Squamous Cell Carcinoma
Kim, J. W., Roh, J., Park, Y., Cho, K., Choi, S., Nam, S. Y., & Kim, S. Y. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-4003-0 · Cited by 15
Marín-Uribe, C. R., & Navarro-Gaete, R. (2021) · Materiales de Construcción · doi:10.3989/mc.2021.11520 · Cited by 17
Metu, C. L. N., Sutihar, S. K., Sohel, M., Zohora, F., Hasan, A., Miah, M. T., Kar, T. R., Hossain, M. A., & Rahman, M. H. (2023) · Cancer Reports · doi:10.1002/cnr2.1889 · Cited by 16
Chang, Y., Rager, J., & Tilton, S. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00333 · Cited by 14
Mutant Ras and inflammation-driven skin tumorigenesis is suppressed via a JNK-iASPP-AP1 axis
Moussawi, K. A., Chung, K., Carroll, T. M., Osterburg, C., Smirnov, A., Lotz, R., Miller, P. F., Dedeić, Z., Zhong, S., Oti, M., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111503 · Cited by 15
Self-citationp53 Target DDA3 binds ASPP2 and inhibits its stimulation on p53-mediated BAX activation
Sun, W.-T., Hsieh, P., Chiang, M.-L., Wang, M.-C., & Wang, F.-F. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.08.168 · Cited by 15
Lora, V., Grings, A. O., Capp, E., Corleta, H. V. E., & Brum, I. S. (2012) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-012-2245-2 · Cited by 15
The ASPP interaction network: electrostatic differentiation between pro‐ and anti‐apoptotic proteins
Benyamini, H., & Friedler, A. (2010) · Journal of Molecular Recognition · doi:10.1002/jmr.1048 · Cited by 15
Liu, C., Luan, J. Y., Bai, Y., Li, Y., Lu, L., Liu, Y., Hakuno, F., Takahashi, S., Duan, C., & Zhou, J. (2013) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2013.12.006 · Cited by 15
P53, Cell Cycle Arrest and Apoptosis
Wang, S., & El‐Deiry, W. S. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_6 · Cited by 17
Downregulation of R-Spondin1 Contributes to Mechanical Stretch-Induced Lung Injury
Xu, C., Liu, Y., Wang, Y., Mao, Y., Xu, D., Dong, W., Zhu, X., & Jiang, L. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003767 · Cited by 14
Wang, C., Gao, C., Chen, Y., Yin, J., Wang, P., & Lv, X. (2013) · Cancer Cell International · doi:10.1186/1475-2867-13-116 · Cited by 14
Mui, M. Z., Zhou, Y., Blanchette, P., Chughtai, N., Knight, J. F., Gruosso, T., Papadakis, A. I., Huang, S., Park, M., Gingras, A., et al. (2015) · Journal of Virology · doi:10.1128/jvi.03710-14 · Cited by 14
Millau, J., Bandele, O. J., Perron, J., Bastien, N., Bouchard, É. F., Gaudreau, L. R., Bell, D. A., & Drouin, R. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq1209 · Cited by 14
Park, S. W., An, C. H., Kim, S. S., Yoo, N. J., & Lee, S. H. (2010) · Gut and Liver · doi:10.5009/gnl.2010.4.2.292 · Cited by 14
Panni, S., Salvioli, S., Santonico, E., Langone, F., Storino, F., Altilia, S., Franceschi, C., Cesareni, G., & Castagnoli, L. (2014) · The Journal of Biochemistry · doi:10.1093/jb/mvu059 · Cited by 14
ΔN-ASPP2, a novel isoform of the ASPP2 tumor suppressor, promotes cellular survival
Hook, K. V., Wang, Z., Chen, D., Nold, C., Zhu, Z., Anur, P., Lee, H.-J., Yu, Z., Sheppard, B. C., Dai, M., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.027 · Cited by 14
Echoes of a Distant Past: The cag Pathogenicity Island of Helicobacter pyloriPreprint
Pacchiani, N., Censini, S., Buti, L., & Covacci, A. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a010355 · Cited by 14
The ASPP proteins complex and cooperate with p300 to modulate the transcriptional activity of p53
Gillotin, S., & Lü, X. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.012 · Cited by 13
Tanman, Ü., Yangın, S., & Cansaran-Duman, D. (2019) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520619666190923163552 · Cited by 13
Zhang, L., Hao, C., Shen, X., Hong, G., Li, H., Zhou, X., Liu, C., & Guo, Z. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2566-2 · Cited by 13
TFIIS.h, a new target of p53, regulates transcription efficiency of pro-apoptotic bax gene
Liao, J., Cao, B., Deng, J., Zhou, X. Y., Strong, M. J., Zeng, S. X., Xiong, J., Flemington, E. K., & Lu, H. (2016) · Scientific Reports · doi:10.1038/srep23542 · Cited by 13
Xu, L., Tong, X., Zhang, S., Yin, F., Li, X., Wei, H., Li, C., Guo, Y., & Zhao, J. (2016) · Tumor Biology · doi:10.1007/s13277-016-5246-0 · Cited by 13
Liu, L., Wang, L., Li, X., Tian, P., Xu, H. Y., Li, Z., & Liu, E. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1664561 · Cited by 13
Drastichová, Z., Rudajev, V., Pallag, G., & Novotný, J. (2021) · Biological Research · doi:10.1186/s40659-021-00327-5 · Cited by 12
Ohata, H., Ota, N., Shirouzu, M., Yokoyama, S., Yokota, J., Taya, Y., & Enari, M. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.09.029 · Cited by 13
Bras, M. L., Bensaad, K., & Soussi, T. (2003) · Oncogene · doi:10.1038/sj.onc.1206424 · Cited by 13
Programmed cell death: Superman meets Dr Death
Meier, P., & Silke, J. (2003) · Nature Cell Biology · doi:10.1038/ncb1203-1035 · Cited by 13
The Biological Function of Hepatitis B Virus X Protein in Hepatocellular Carcinoma
Xu, Q., Gu, S., Liang, J., Lin, Z., Zheng, S., & Jiang, Y. (2018) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504018x15278771272963 · Cited by 12
Liu, D., Ertay, A., Hill, C. N., Zhou, Y., Li, J., Zou, Y., Qiu, H., Yuan, X., Ewing, R. M., Lü, X., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2415-2 · Cited by 12
Patel, J. B., Patel, K. D., Patel, S. R., Shah, F. D., Shukla, S. N., & Patel, P. S. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.5.1727 · Cited by 12
Fagerholm, R., Khan, S., Schmidt, M. K., García‐Closas, M., Heikkilä, P., Saarela, J., Beesley, J., Jamshidi, M., Aittomäki, K., Liu, J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15110 · Cited by 12
Wang, S., Sun, Y., Wang, Y., Wang, A., Kou, B., Che, Y., Chen, D., Zhang, Y., & Shi, Y. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16699 · Cited by 11
Investigation on the Potential Correlation Between TP53 and Esophageal Cancer
Yao, L., Zhong, X., Huang, G., Ma, Q., Xu, L., Xiao, H., & Guo, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.730337 · Cited by 11
Berge, E. O., Huun, J., Lillehaug, J. R., Lønning, P. E., & Knappskog, S. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.12.004 · Cited by 12
How p53 wields the scales of fate
Goh, A. M., & Lane, D. P. (2012) · Transcription · doi:10.4161/trns.21297 · Cited by 11
Woodard, C. L., Liao, G., Goodwin, C. R., Hu, J., Xie, Z., dos Reis, T. F., Newman, R. H., Rho, H., Qian, J. X., Zhu, H., et al. (2015) · Journal of Virology · doi:10.1128/jvi.01072-15 · Cited by 11
Iosub‐Amir, A., van Rosmalen, M., Mayer, G., Lebendiker, M., Danieli, T., & Friedler, A. (2015) · Scientific Reports · doi:10.1038/srep11629 · Cited by 11
iASPP, A potential drug target in cancer therapy
Gillotin, S. (2009) · Leukemia Research · doi:10.1016/j.leukres.2009.04.037 · Cited by 11
Dapas, M., Thompson, E. E., Wentworth-Sheilds, W., Clay, S. M., Visness, C. M., Calatroni, A., Sordillo, J. E., Gold, D. R., Wood, R. A., Makhija, M., et al. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010594 · Cited by 10
Reingewertz, T. H., Iosub‐Amir, A., Bonsor, D. A., Mayer, G., Amartely, H., Friedler, A., & Sundberg, E. J. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00084 · Cited by 10
The Caenorhabditis elegans ASPP homolog APE-1 is a junctional protein phosphatase 1 modulator
Beacham, G. M., Wei, D. T., Beyrent, E., Zhang, Y., Zheng, J., Camacho, M. M. K., Florens, L. A., & Hollopeter, G. (2022) · Genetics · doi:10.1093/genetics/iyac102 · Cited by 10
A Functional Variant rs1820453 in YAP1 and Breast Cancer Risk in Chinese Population
Chen, W., Wang, W., Zhu, B., Guo, H., Sun, Y., Ming, J., Shen, N., Li, Z., Wang, Z., Liu, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079056 · Cited by 10
Öhman, T., Söderholm, S., Hintsanen, P., Välimäki, E., Lietzén, N., MacKintosh, C., Aittokallio, T. A., Matikainen, S., & Nyman, T. A. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.038968 · Cited by 10
Regulation of p53 isoform expression in renal cell carcinoma
Heikaus, S. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e162 · Cited by 10
Ma, Y., Zhu, B., Liu, X., Liu, Z., Jiang, L., Wei, F., Yu, M., Wu, F., Zhou, H., Xu, N., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20190 · Cited by 10
Nichols, A., Chan-Seng-Yue, M., Yoo, J., Agrawal, S., Starmans, M., Waggott, D., Harding, N., Dowthwaite, S., Palma, D., Fung, K., et al. (2013) · Case Reports in Oncological Medicine · doi:10.1155/2013/270362 · Cited by 9
Mdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradation
Bergamaschi, D., Samuels, Y., Zhong, S., & Lü, X. (2005) · Oncogene · doi:10.1038/sj.onc.1208535 · Cited by 10
Self-citationBrn-3a/POU4F1 interacts with and differentially affects p73-mediated transcription
Hudson, C. D., Sayan, E., Melino, G., Knight, R. A., Latchman, D. S., & Budhram-Mahadeo, V. S. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.45 · Cited by 10
Cdk5 mediates rotational force-induced brain injury
Umfress, A., Chakraborti, A., Devi, S. P. S., Adams, R., Epstein, D., Massicano, A. V. F., Sorace, A. G., Singh, S., Hossian, M. I., Andrabi, S. A., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-29322-4 · Cited by 10
Protein–protein interactions of ASPP2: an emerging therapeutic target
Iosub‐Amir, A., & Friedler, A. (2014) · MedChemComm · doi:10.1039/c4md00147h · Cited by 9
Moreno, O. M., Sánchez, A. I., Herreño, A. M., Giraldo, G. A., Suárez‐Obando, F., Prieto, J. C., Clavijo, A. S., Olaya, M., Vaca, Y. A. V., Benitez, J. J., et al. (2020) · Molecular Syndromology · doi:10.1159/000510910 · Cited by 10
Targeted splicing therapy: new strategies for colorectal cancer
Zheng, Y., Zhong, G., He, C., & Li, M. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1222932 · Cited by 9
ATF4 Signaling in HIV-1 Infection: Viral Subversion of a Stress Response Transcription Factor
Corne, A., Adolphe, F., Estaquier, J., Gaumer, S., & Corsi, J.-M. (2024) · Biology · doi:10.3390/biology13030146 · Cited by 7
Qiu, S., Cai, Y., Gao, X., Gu, S.-Z., & Liu, Z.-J. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.10.044 · Cited by 9
FHL2 interacts with iASPP and impacts the biological functions of leukemia cells
Lu, W., Yu, T., Liu, S., Li, S., Li, S., Liu, J., Xu, Y., Xing, H., Tian, Z., Tang, K., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16617 · Cited by 9
Proteomic Analysis Uncovers Measles Virus Protein C Interaction With p65–iASPP Protein Complex
Meignié, A., Combredet, C., Santolini, M., Kovács, I. A., Douché, T., Gianetto, Q. G., Eun, H., Matondo, M., Jacob, Y., Grailhe, R., et al. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100049 · Cited by 9
Mechanisms of Apoptosis Resistance In Breast Cancer
Yang, L. P. H. (2007) · Springer eBooks · doi:10.1007/978-3-540-28266-2_39 · Cited by 9
Taaffe, J. E., Bosinger, S. E., Prete, G. Q. D., Else, J. G., Ratcliffe, S. J., Ward, C. D. W., Migone, T., Paiardini, M., & Silvestri, G. (2011) · Journal of Medical Primatology · doi:10.1111/j.1600-0684.2011.00521.x · Cited by 9
Schipper, K., Drenth, A. P., van der Burg, E., Cornelissen, S., Klarenbeek, S., Nethe, M., & Jonkers, J. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3607 · Cited by 10
ASPP2 Is Phosphorylated by CDK1 during Mitosis and Required for Pancreatic Cancer Cell Proliferation
Xiao, Y., Chen, Y., Chen, J., & Dong, J. (2023) · Cancers · doi:10.3390/cancers15225424 · Cited by 8
Wang, L., Xu, Z., Yang, P., LI, L.-C., & Wu, X. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3587 · Cited by 8
Knockout of ASPP2 promotes DEN-induced hepatocarcinogenesis via the NF-κB pathway in mice
Wang, S., Kou, B., Chai, M., Gao, Y., Lin, X., Yin, L., Chen, D., & Liu, X. (2021) · Cancer Gene Therapy · doi:10.1038/s41417-021-00300-0 · Cited by 8
Tan, D., Chen, K. E., Deng, C., Tang, P., Huang, J., Mansour, T., Luben, R. A., & Walker, A. M. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.12.030 · Cited by 8
Micheal, S., Saksens, N. T. M., Hogewind, B. F. T., Khan, M. I., Hoyng, C. B., & den Hollander, A. I. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0403-z · Cited by 9
Wang, L., Xing, H., Tian, Z., Peng, L., Li, Y., Tang, K., Rao, Q., Wang, M., & Wang, J.-X. (2012) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2012.06.124 · Cited by 9
Cell type specific expression of the apoptosis stimulating protein (ASPP-2) in human tissues
Alenzi, F. Q. (2010) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/amicr.57.2010.4.8 · Cited by 8
ASPP2 deficiency causes features of 1q41q42 microdeletion syndrome
Žák, J., Vives, V., Szumska, D., Vernet, A., Schneider, J. E., Miller, P. F., Slee, E. A., Joss, S. K., Lacassie, Y., Chen, E., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.76 · Cited by 8
Deep Phosphoproteomic Measurements Pinpointing Drug Induced Protective Mechanisms in Neuronal Cells
Yu, C., Gao, J., Zhou, Y., Chen, X., Xiao, R., Zheng, J., Liu, Y., & Zhou, H. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00635 · Cited by 8
Using TUNEL Assay to Quantitate p53-Induced Apoptosis in Mouse Tissues
Resnick‐Silverman, L. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1217-0_12 · Cited by 8
P53 and other Cell Cycle Regulators
Farid, N. R. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/1-4020-8107-3_8 · Cited by 8
Qian, Y., Jung, Y.-S., & Chen, X. (2012) · Cell Cycle · doi:10.4161/cc.21962 · Cited by 8
Zhou, X., Zhuo, H., Lin, L., Zhang, Y., Li, J., Fu, S., Wu, G., Guo, C., & Liu, J. (2024) · Aquaculture Reports · doi:10.1016/j.aqrep.2024.102413 · Cited by 7
Predator: Predicting the Impact of Cancer Somatic Mutations on Protein-Protein Interactions
Berber, I., Erten, C., & Kazan, H. (2023) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2023.3262119 · Cited by 7
Nucleostemin and ASPP2 expression is correlated with pituitary adenoma proliferation
Ma, L., Chen, Z. H., LI, X.-Y., Wang, X., Shou, J., & Fu, X. (2013) · Oncology Letters · doi:10.3892/ol.2013.1562 · Cited by 7
Chromosomal imbalances in successive moments of human bladder urothelial carcinoma
Pontes, M. G. N. E., Silveira, S. M., Filho, J. C. D. S. T., Rogatto, S. R., & de Camargo, J. L. V. (2011) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2011.05.015 · Cited by 7
Gao, K., An, J., Zhang, Y., Jin, X., Ma, J., Peng, J., Tang, Y., Yu, L., Zhang, P., & Wang, C. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.11.030 · Cited by 7
Thichanpiang, P., Khanobdee, K., Kitiyanant, Y., & Wongprasert, K. (2013) · Journal of Agricultural Science · doi:10.5539/jas.v5n4p43 · Cited by 7
Guthrie, O. W. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.08.010 · Cited by 7
Liu, R., Wang, X., Curtiss, C. M., Sheikh, M. S., & Huang, Y. K. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0549-5 · Cited by 7
Hzf and hCAS/CSE1L: making the right choice in p53-mediated tumour suppression
Ewings, K. E., & Ryan, K. (2007) · Cell Research · doi:10.1038/cr.2007.85 · Cited by 7
Xie, X.-F., Yang, Q. H., Chi, J., Yang, X.-Z., Wang, H., & Xu, G.-L. (2017) · 癌症:英文版 · doi:10.1186/s40880-016-0169-0 · Cited by 7
The Presence of a Short Form of p53 in Chicken Lymphoblastoid Cell Lines during Apoptosis
Takagi, M., Takeda, T., Asada, Y., Sugimoto, C., Onuma, M., & Ohashi, K. (2006) · Journal of Veterinary Medical Science · doi:10.1292/jvms.68.561 · Cited by 7
Senju, Y., & Hibino, E. (2022) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2022.184076 · Cited by 6
The Role of p53 in HIV Infection
Yaseen, M. M., Abuharfeil, N. M., & Darmani, H. (2023) · Current HIV/AIDS Reports · doi:10.1007/s11904-023-00684-8 · Cited by 7
iASPP: A Novel Protein Involved in Pituitary Tumorigenesis?
Pinto, E. M., Musolino, N. R. D. C., Cescato, V. Â. S., Soares, I. C., Wakamatsu, A., de Oliveira, E., Salgado, L. R., & Bronstein, M. D. (2010) · Frontiers of hormone research · doi:10.1159/000318496 · Cited by 6
Liu, Z., Xin, H., Chen, J., Lü, X., Zhong, S., Gu, S.-Z., Wang, G. G., Liu, L., Cai, Y., & Hou, L. (2006) · Leukemia Research · doi:10.1016/j.leukres.2006.09.014 · Cited by 6
Self-citationEffects of C heavy ion beam irradiation on the p53 signaling pathway in HepG2 liver cancer cells
Liu, K., Zhao, X., Gu, J., Wu, J., Zhang, H., & Li, Y. (2017) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx096 · Cited by 6
Analysis of an artificially selected GS‐NS0 variant with increased resistance to apoptosis
Browne, S. M., & Al‐Rubeai, M. (2010) · Biotechnology and Bioengineering · doi:10.1002/bit.22994 · Cited by 6
McKinney, K. M., & Prives, C. L. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_2 · Cited by 6
Metadata
- Authors
- Samuels-Lev, Y., O'Connor, D. J., Bergamaschi, D., Trigiante, G., Hsieh, J.-K., Zhong, S., Campargue, I., Naumovski, L., Crook, T., & Lu, X.
- Affiliations
- Ludwig Cancer Research (GB)
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2001-10
- Volume
- 8
- Issue
- 4
- Pages
- 781-794
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W2087732778
- Cited by
- 664
- References
- 22
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 15 · 2023: 20 · 2022: 16 · 2021: 26 · 2020: 13 · 2019: 20 · 2018: 8 · 2017: 27 · 2016: 18 · 2015: 23 · 2014: 37 · 2013: 35 · 2012: 31
- FWCI
- 13.67
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Molecular Cell (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- ASPP1, ASPP2, p53, apoptosis, p53 DNA binding, p53 transactivation, tumor suppression, breast cancer, mutant p53, cell cycle arrest
- MeSH terms
- Breast Neoplasms, Carcinoma, Carrier Proteins, Cell Separation, Female, Flow Cytometry, Humans, Microscopy, Fluorescence, Molecular Sequence Data, Peptide Fragments, Promoter Regions, Genetic, Proto-Oncogene Proteins, Tumor Cells, Cultured, Transcriptional Activation, Tumor Suppressor Protein p53, Cyclins, Apoptosis, Protein Structure, Tertiary, Proto-Oncogene Proteins c-bcl-2, Cyclin-Dependent Kinase Inhibitor p21, Apoptosis Regulatory Proteins, bcl-2-Associated X Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review